| Original language | English |
|---|---|
| Pages (from-to) | 328-329 |
| Number of pages | 2 |
| Journal | Current Opinion in Lipidology |
| Volume | 32 |
| Issue number | 5 |
| DOIs |
|
| State | Published - Oct 1 2021 |
Funding
The authors’ research work is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under grant number R01HL139748 and R35HL155649 and the American Heart Association SFRN in Vascular Disease (18SFRN33960163). The content in this commentary is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | R01HL139748 |
| National Heart, Lung, and Blood Institute (NHLBI) | R35HL155649 |
| American the American Heart Association | 18SFRN33960163 |
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Molecular Biology
- Genetics
- Nutrition and Dietetics
- Cardiology and Cardiovascular Medicine
- Cell Biology
